Valvular & structural heart disease

Transcatheter Aortic Valve Implantation for Combined Aortic and Mitral Stenoses: Insights from the OCEAN-TAVI Registry

ESC Heart FailPublished Registry-based cohort study

Authors' conclusion

In patients undergoing TAVI for severe AS, those with moderate or severe MS experienced worse outcomes after TAVI compared with those without MS.

Study context

Population
Patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) in the OCEAN-TAVI registry
Participants
106 vs 6,570
Exposure
Mitral stenosis (MS) vs no MS in patients undergoing TAVI for severe AS
  • MSn = 106
  • Controlsn = 6,570reference
Outcome
Composite of:
  • All-cause death
  • Admission for HF
Follow-up
Median 2.1 years
Methodological detailsOCEAN-TAVI registry, propensity score matched analysis
  • OCEAN-TAVI registry
  • Propensity score matched analysis

Main finding

As reported in the abstract

Composite of:
  • All-cause death
  • HF admission
MS vs ControlsAdjusted hazard ratio (95% CI)P value
Composite of all-cause death and HF admission
1.84(1.34–2.51)
P < 0.01
Propensity score matched analysis
1.91(1.14–3.22)
P < 0.01

Observational data: associations, not effects.

Further findings

30-day mortality

P = 0.18

Early composite outcomes

P = 0.56

Adverse events by moderate or severe mitral annulus calcification (MAC) (MS subgroup)

Adjusted HR (95% CI)P value
Moderate or severe MAC2.89 (1.20–6.99)P = 0.018

NYHA class 3 or 4 (MS) · baseline and 1 year after TAVI

NYHA class 3 or 4 at baseline
56%
NYHA class 3 or 4 at 1 year
6%

Adverse events by moderate or severe MAC (MS subgroup)

Transmitral gradient (TMG) and mitral valve area (MVA) did not contribute to increased risk

Original publication

Transcatheter Aortic Valve Implantation for Combined Aortic and Mitral Stenoses: Insights from the OCEAN-TAVI Registry. ESC Heart Fail. Published 21 August 2024. doi:10.1002/ehf2.15030

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.